Adherence to the anti-epileptic drugs among children with epilepsy- a cross sectional study in a tertiary care hospital

Baljinder Kaur; Anju Singla; Amandeep Kaur; Surinder Kaur; Kulwant Rai

doi:10.18203/2349-3291.ijcp20223420

Authors

Baljinder Kaur Department of Pediatrics, Government Medical College and Rajindra Hospital, Patiala, India
Anju Singla Department of Pediatrics, Government Medical College and Rajindra Hospital, Patiala, India
Amandeep Kaur Department of Pediatrics, Government Medical College and Rajindra Hospital, Patiala, India
Surinder Kaur Department of Pediatrics, Government Medical College and Rajindra Hospital, Patiala, India
Kulwant Rai Department of Pediatrics, Government Medical College and Rajindra Hospital, Patiala, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20223420

Keywords:

Epilepsy, AEDs, Non-adherence, Children

Abstract

Background: Epilepsy is the commonest chronic and highly stigmatized neurological problem that affects many children. It is defined by two or more unprovoked seizures. The main stay of the epilepsy management is the anti-epileptic drugs and strict adherence to anti-epileptic drugs is the key to successful treatment. The 70% of children will become seizure free with appropriate anti-epileptic drug (AED) treatment. The goal of treatment of epilepsy includes minimizing the risk of recurrent seizures and side effects, and maintaining normal psychosocial and educational/vocational adjustment. Our study will assess the level of adherence to AEDs in children and factor associated with non-adherence.

Methods: A cross-sectional prospective descriptive design study, conducted in Government medical college and Rajindra hospital, Patiala, Punjab from December 2021 to May 2021. 60 patients were included in this study who gave written consent and had been taking at least one AEDs for at least 6 months. Only those patients with normal neurological and cognitive development and no other severe comorbidities were included in this study. Patients and their parents were individually administered a structured questionnaire consisting of personal and demographic Information, self-prepared questionnaire to check compliance and validated questionnaire called Morisky medication adherence scale (MMAS-8). Data was analysed by using statistical package for social science software and p<0.05 considered as significant to see the association between factors and non-adherence.

Results: The most common reason for non-compliance was problem in remembering that was seen in 41.8% of the patients. 21.8% of the patients had problems in sticking themselves and 18.6% had problems with buying the drugs. 60% patients are male.

Conclusions: Poor adherence was seen in 50% of our study participants. In our study, patients were not stick to their therapy, buy the drugs or had problem to remember to take their medication.

Metrics

Metrics Loading ...

References

Epilepsy: epidemiology, etiology and prognosis. Geneva, World Health Organization, 2001 (WHO Fact Sheet No 165. Available at: http://www.who.int/inf-fs/en/fact165.html. Accessed on 20 Oct, 2022.

Camfield P, Camfield C. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology. 2005;64:973-5.

Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110:207-20.

Fountain NB. Choosing among antiepileptic drugs. Continuum: Lifelong Learning in Neurology 2010;16:121-135.

Sabate E. Defining adherence, WHO Adherence Meeting Report. In: Sabate E, editor. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: WHO; 2003: 3.

Gomes MM, Maia FHS, Noe RA. Anti-epileptic drug intake adherence: The value of the blood drug level measurement and the clinical approach. Arq Neuropsych. 1998;56:708-13.

Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207.

Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W. Compliance with treatment of adult epileptics in a rural district of Thailand. J Med Assoc Thai. 2003;86:46-51.

Enriquez-Caceres M, Soto-Santillana M. Non-compliance with pharmacological treatment in patients with epilepsy. Rev Neurol. 2006;42:647-54.

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.

Snodgrass SR, Parks BR. Anticonvulsant blood levels: historical review with a pediatric focus. J Child Neurol. 2000;15:734-46.

Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54.

Fadare JO, Sunmonu TA, Bankole IA, Adekeye KA, Abubakar SA. Medication adherence and adverse effect profile of antiepileptic drugs in Nigerian patients with epilepsy. Neurodegener Dis Manag. 2018;8:25-36.

Pattoo FH, Alshayban DM, Joseph R, Al-Musa F, Al-Jabran O, Aliaafari D. Impact of adherence to antiepileptic medications on quality of life of epileptic patients in the Eastern province of Saudi Arabia: a cross-sectional study. Imam J Appl Sci. 2020;5:1-8.

Yang C, Yu D, Li J, Zhang L. Prevalence of medication adherence and factors influencing adherence to antiepileptic drugs in children with epilepsy from western China: a cross-sectional survey. Epilepsy Behav. 2020;104:106662.

Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M. Adherence to treatment in patients with epilepsy: Associations with seizure control and illness beliefs. Seizure. 2006;15:504-8.

Chapman SC, Horne R, Chater A, Hukins D, Smithson WH. Patients’ perspectives on antiepileptic medication: Relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav. 2014;31:312-20.

Modi AC, Guilfoyle SM. Ad- herence to antiepileptic drug therapy across the develop- mental life-span. In: Pinika- hana J, Walker C, editors. Society, Behaviour and Epi- lepsy. New York, NY: Nova Science Publishers Inc. 2011;175-205.

Mbuba CK, Ngugi AK, Fegan G. Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study. Lancet Neurol. 2012;11:688-96.

Liu J, Liu Z, Ding H, Yang X. Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients. Epileptic Dis. 2013;15(3):289-94.

Jung S, Tak SH. Medication Non-adherence and Related Factors of Older Adults Who Use Polypharmacy Based on Medication Adherence Model. J Korea Contents Assoc. 2019;19(12):398-406.

Chauhan S, Prasad PL, Bhawana Khurana B, Gahalaut P. Self-reported medication adherence to antiepileptic drugs and treatment satisfaction among paediatric patients having epilepsy: a cross sectional study from the Indian subcontinent. Sri Lanka J Child Health. 2018;47:129-36.

Hovinga CA, Asato MR, Manjunath R, Wheless JW, Phelps SJ, Sheth RD. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav. 2008;13:316-22.

Tan XC, Makmor Bakry M, Lau CL, Tajarudin FW, Ali RA. Factors affecting adherence to antiepileptic drugs therapy in Malaysia. Neurol Asia. 2015;20:235-41.

Gurumurthy R, Chanda K, Sarma G. An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: a cross-sectional study. Singapore Med J. 2017;58:98-102.

Hasiso TY, Desse TA. Adherence to treatment and factors affecting adherence of epileptic patients at Yirgalem General Hospital, Southern Ethiopia: a prospective cross-sectional study. PLoS One. 2016;11:e0163040.

Liu J, Liu Z, Ding H, Yang X. Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients. Epileptic Disord. 2013;15:289-94.

Kassahun G, Moges G, Demessie Y. Assessment of patients’ adherence to antiepileptic medications at Dessie referral hospital, chronic follow-up, South Wollo, Amhara region, North East Ethiopia. Neurol Res Int. 2018;2018:5109615.

Al-Ramahi R. Adherence to medications and associated factors: a cross-sectional study among Palestinian hypertensive patients. J Epidemiol Glob Health. 2015;5:125-32.